An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system

Richter’s syndrome (RS) of the central nervous system (CNS) is known to have an extremely poor prognosis. Ibrutinib has been reported to have some activity in patients with RS, despite its poor prognosis. Although ibrutinib crosses the blood-brain barrier, its efficacy in RS patients with CNS involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nato, Yuma, Nagaharu, Keiki, Inoue, Kanako, Yabu, Kodai, Sawaki, Akihiko, Shiotani, Takuya, Kageyama, Yuki, Tanaka, Ken, Ohshima, Koichi, Miyashita, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898719/
https://www.ncbi.nlm.nih.gov/pubmed/36436931
http://dx.doi.org/10.3960/jslrt.22017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898719/
https://www.ncbi.nlm.nih.gov/pubmed/36436931
http://dx.doi.org/10.3960/jslrt.22017

Ejemplares similares